| Typicality: | 0.434 |
| Saliency: | 0.432 |
| in blood | 9 | location |
| in a subset of children | 7 | other |
| by studying both prostate cancer patients | 5 | manner |
| researcher → identify → biomarker | 34 |
| researcher → identified → biomarker | 14 |
| researcher → hope to identify → biomarker | 3 |
| researcher → try to identify → biomarker | 3 |
| negative | neutral | positive |
| 0.096 | 0.708 | 0.196 |
| Raw frequency | 54 |
| Normalized frequency | 0.432 |
| Modifier score | 0.500 |
| Perplexity | 247.734 |